醫療保健 · 2026 年 9 月 18 日更新 · 閱讀 9 分鐘
中國醫藥企業員工薪酬
This analysis compares A-share companies classified as Pharmaceuticals in the supplied industry dataset. Medical-device and other health-care service companies classified elsewhere are excluded.
重點摘要
Among 283 A-share pharmaceutical companies, median reported average compensation was CN¥172,683 in 2025, compared with a mean of CN¥199,847.
Companies
283
Pharmaceuticals industry
2025 median
CN¥172,683
Company observations
2025 mean
CN¥199,847
Sensitive to outliers
Business differences among pharmaceutical companies
A research-heavy drug developer and a business with a large manufacturing workforce have different staff mixes. The company table is a starting point for disclosure research, not a ranking adjusted for those business differences.
Top 30 pharmaceutical compensation observations in 2025
方法與限制
- 平均薪酬由公司披露的員工人數及員工薪酬相關數據推算,不代表每名員工的實際薪資。
- 我們採用中位數降低極端值對行業比較的影響,並同時列出平均數作參考。
- 缺失值不納入計算;年度比較只包括兩個期間均有數據的公司。
- 本文僅提供事實性數據分析,不構成投資建議、薦股或資產管理服務。
- The sample includes companies classified as 医药 (Pharmaceuticals) in the supplied industry dataset.